DC.ID,SMILES_stand,InChI,SMILES,DC.NAME,NCATS.SYNONYMS,NCGC.ID,ACE2.ACTIVITY,ACE2.SIGNIFICANCE,logPow {predicted by ochem.eu/model/535 in Log unit},Aqueous Solubility {predicted by ochem.eu/model/536 in log(mol/L)},Label
2340.0,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,quinapril,Quinapril hydrochloride,,LOW,INACTIVE,1.38,-4.71,0
1297.0,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12,,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12,glafenine,Glafenine hydrochloride,,MODERATE,MODERATE,2.76,-4.04,1
,CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12,,CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12,,Abexinostat,,LOW,INACTIVE,1.79,-3.71,0
,Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2,,Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2,,CB-5083,,HIGH,LOW,3.32,-4.43,1
,O=C(CCCCCCC(=O)NN=Cc1ccc(N(c2ccccc2)c2ccccc2)cc1)NO,,O=C(CCCCCCC(=O)N/N=C/c1ccc(N(c2ccccc2)c2ccccc2)cc1)NO,,WT-161,,MODERATE,HIGH,4.98,-5.79,1
,O=C([O-])c1cc(=O)c2c3nc4ccccc4oc-3cc(=O)c2[nH]1,,O=C([O-])c1cc(=O)c2c3nc4ccccc4oc-3cc(=O)c2[nH]1,,Pirenoxine Sodium,,MODERATE,LOW,1.78,-3.15,1
760.0,CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,ciclosporin,Cyclosporine A|Cyclosporin A,NCGC00093704-19,LOW,INACTIVE,4.12,-5.09,0
871.0,CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(O)CC#N,,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N,dienogest,Dienogest,NCGC00346502-06,LOW,INACTIVE,3.38,-3.61,0
2282.0,CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1,,CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1,proguanil,Proguanil hydrochloride,,LOW,INACTIVE,2.29,-3.35,0
,c1ccc(CNc2nc(NCc3ccccc3)c3ccccc3n2)cc1,,c1ccc(CNc2nc(NCc3ccccc3)c3ccccc3n2)cc1,,KUC105555N,,HIGH,MODERATE,4.99,-5.19,1
5203.0,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,rucaparib,Rucaparib,,HIGH,HIGH,2.39,-4.45,1
,COc1ccnc2c1CCCCC2S(=O)c1nc2ccccc2[nH]1,,COc1ccnc2c1CCCCC2S(=O)c1nc2ccccc2[nH]1,,Nepaprazole,,HIGH,HIGH,2.47,-3.11,1
3137.0,N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2Br)c(Br)c1,,N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2Br)c(Br)c1,dibrompropamidine,Dibromopropamidine dihydrochloride,,MODERATE,HIGH,2.35,-4.56,1
249.0,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,astemizole,Astemizole,,LOW,INACTIVE,5.92,-5.58,0
,Cc1nnc2n1-c1sc(CCC(=O)N3CCOCC3)cc1C(c1ccccc1Cl)=NC2,,Cc1nnc2n1-c1sc(CCC(=O)N3CCOCC3)cc1C(c1ccccc1Cl)=NC2,,Apafant,,HIGH,LOW,3.01,-4.06,1
,CCCCCCCCCCCCCCCCn1cc[n+](Cc2ccccc2)c1C,,CCCCCCCCCCCCCCCCn1cc[n+](Cc2ccccc2)c1C,,NH125,,MODERATE,LOW,4.94,-6.09,1
,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,,CCN(CC)C(=O)N[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@@H]2N(C)C1,,"(-)-(5S,8R)-Lisuride",,MODERATE,MODERATE,2.38,-3.38,1
,Cc1cc(Nc2ccccc2C(=O)O)ccc1Cl,,Cc1cc(Nc2ccccc2C(=O)O)ccc1Cl,,2-[(4-Chloro-3-methylphenyl)amino]benzoic acid,,MODERATE,MODERATE,4.7,-4.25,1
,CCNCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O,,CCNCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O,,Gardiquimod,,LOW,INACTIVE,1.55,-3.19,0
,[H]C([H])([H])C(O)(CCOC(C)C1CCC2C(=CC=C3CC(O)CC(O)C3=C)CCCC21C)C([H])([H])[H],,[2H]C([2H])([2H])C(O)(CCO[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3/C[C@@H](O)C[C@H](O)C3=C)CCC[C@]12C)C([2H])([2H])[2H],,Maxacalcitol-D6,,LOW,INACTIVE,4.51,-4.46,0
3253.0,COC1C(OC(=O)C=CC=CC=CC=CC(=O)O)CCC2(CO2)C1C1(C)OC1CC=C(C)C,,CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CO2,fumagillin,Fumagillin,,LOW,INACTIVE,4.61,-5.16,0
3254.0,CCCCCC(O)C1C(=O)OC(C)C(O)C=CC=CC=CC=CC=C(C)C(O)C(O)C(O)CC(O)CC(O)CC(O)CC(O)CC1O,,CCCCC[C@@H](O)[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C/C=C/C=C/C=C/C=C(\C)[C@@H](O)[C@H](O)[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O,pentamycin,Pentamycin,,LOW,INACTIVE,1.26,-3.51,0
,Cc1ccc(C2Nc3ccccc3C(=O)N2c2ccccc2)s1,,Cc1ccc(C2Nc3ccccc3C(=O)N2c2ccccc2)s1,,Retro-2,,MODERATE,MODERATE,3.59,-4.63,1
,CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(S(=O)Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1,,CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S@@](=O)Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1,,Cenicriviroc Mesylate,,LOW,INACTIVE,6.26,-5.95,0
607.0,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,chloroquine,Chloroquine,NCGC00015256-17,MODERATE,INACTIVE,5.29,-4.28,1
5077.0,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,selexipag,NS-304,,LOW,INACTIVE,4.4,-5.06,0
5215.0,COc1ccc2c(c1)C1CC1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,beclabuvir,BMS-791325 hydrochloride,,HIGH,HIGH,4.47,-5.19,1
4299.0,CC(C)c1nc(CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,cobicistat,Cobicistat,,LOW,INACTIVE,4.35,-5.79,0
5256.0,COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,,COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,copanlisib,Copanlisib,NCGC00346457-03,MODERATE,HIGH,1.0,-3.32,1
3487.0,CCCCOc1ccc(OCCCN2CCOCC2)cc1,,CCCCOc1ccc(OCCCN2CCOCC2)cc1,pramocaine,Pramoxine hydrochloride,,HIGH,LOW,3.02,-3.12,1
1120.0,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2C(N)CC3,,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](N)CC3,exatecan,Exatecan,,HIGH,LOW,1.67,-3.29,1
4554.0,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,fluticasone furoate,Fluticasone furoate,,LOW,INACTIVE,3.73,-4.09,0
,S=C([S-])OC1CC2CC1C1CCCC21,,S=C([S-])O[C@H]1C[C@H]2C[C@@H]1[C@@H]1CCC[C@H]21,,SPK-601,,LOW,INACTIVE,3.91,-4.91,0
1987.0,Cc1[nH]c(=O)c(C#N)cc1-c1ccc2nccn2c1,,Cc1[nH]c(=O)c(C#N)cc1-c1ccc2nccn2c1,olprinone,Olprinone,,LOW,INACTIVE,1.88,-3.44,0
2106.0,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,perhexiline,Perhexiline,,MODERATE,INACTIVE,5.86,-7.01,1
4875.0,COC(=O)NC(C(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCN5C(=O)C(NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,daclatasvir,Daclatasvir dihydrochloride,NCGC00346533-13,HIGH,HIGH,4.67,-4.94,1
,O=C1C2CC=CCC2C(=O)N1SC(Cl)(Cl)Cl,,O=C1C2CC=CCC2C(=O)N1SC(Cl)(Cl)Cl,,Captan,,LOW,INACTIVE,3.0,-3.87,0
170.0,CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C,,CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C,dimevamide,Aminopentamide sulfate,,LOW,INACTIVE,2.62,-4.01,0
,COc1cccc2c(NCc3ccccc3)nc(-n3c(N)nc4ccccc43)nc12,,COc1cccc2c(NCc3ccccc3)nc(-n3c(N)nc4ccccc43)nc12,,KUC107871N,NCGC00347064-04,MODERATE,HIGH,4.34,-4.56,1
616.0,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,chlorphenamine,Dexchlorpheniramine hydrochloride,,LOW,INACTIVE,3.74,-3.72,0
868.0,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,dicycloverine,Dicyclomine,,LOW,INACTIVE,5.82,-4.98,0
,O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1,,O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1,,JZL-184,,LOW,INACTIVE,3.42,-4.76,0
,O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,,O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,,OXANTEL PAMOATE,,LOW,INACTIVE,4.4,-4.97,0
182.0,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1,,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1,amlexanox,Amlexanox,NCGC00167472-10,HIGH,HIGH,2.76,-3.31,1
1809.0,Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1,,Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1,milrinone,Milrinone,NCGC00015675-22,LOW,INACTIVE,1.04,-3.0,0
218.0,COc1ccc(-c2cc(=S)ss2)cc1,,COc1ccc(-c2cc(=S)ss2)cc1,anethole trithione,Anethole trithione,,HIGH,LOW,3.59,-4.44,1
,CS(=O)(=O)c1ccc(-c2nnc(C=Cc3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)nc1,,CS(=O)(=O)c1ccc(-c2nnc(/C=C/c3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)nc1,,G-007-LK,NCGC00390587-01,HIGH,HIGH,3.69,-3.69,1
663.0,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,citalopram,Citalopram hydrobromide,,LOW,INACTIVE,3.58,-4.74,0
328.0,O=C(OOC(=O)c1ccccc1)c1ccccc1,,O=C(OOC(=O)c1ccccc1)c1ccccc1,benzoyl peroxide,Benzoyl peroxide,,HIGH,HIGH,2.74,-3.92,1
318.0,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,benzbromarone,Benzbromarone,,MODERATE,MODERATE,5.54,-4.51,1
,CCC(NC(=O)C(C)NC)C(=O)N1CC(O)CC1Cc1c(-c2[nH]c3cc(F)ccc3c2CC2CC(O)CN2C(=O)C(CC)NC(=O)C(C)NC)[nH]c2cc(F)ccc12,,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12,,Birinapant,,MODERATE,LOW,2.21,-4.36,1
2531.0,O=C1OC(c2ccc(O)c(S(=O)(=O)O)c2)(c2ccc(O)c(S(=O)(=O)O)c2)c2c(Br)c(Br)c(Br)c(Br)c21,,O=C1OC(c2ccc(O)c(S(=O)(=O)O)c2)(c2ccc(O)c(S(=O)(=O)O)c2)c2c(Br)c(Br)c(Br)c(Br)c21,sulfobromophthalein,Sulfobromophthalein,,HIGH,HIGH,1.03,-5.01,1
1440.0,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,indomethacin,Indomethacin,,MODERATE,LOW,4.25,-5.17,1
5262.0,COc1cccc(N2CCN(C3=Nc4c(F)cccc4C(CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1,,COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1,letermovir,Letermovir,,LOW,INACTIVE,4.58,-4.76,0
1043.0,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)CC21,,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,ergotamine,Ergotamine tartrate,,MODERATE,INACTIVE,2.51,-3.44,1
4716.0,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,ponatinib,Ponatinib,NCGC00263152-15,HIGH,LOW,3.94,-5.26,1
556.0,CC=CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(N)c3ccc(O)cc3)C2SC1,,C/C=C/C1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1,cefprozil,Cefprozil,,LOW,INACTIVE,1.19,-3.42,0
2036.0,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O,,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O,oxyphenbutazone,Oxyphenbutazone,,LOW,INACTIVE,2.79,-3.09,0
2266.0,COc1cc(NC(C)CCCN)c2ncccc2c1,,COc1cc(NC(C)CCCN)c2ncccc2c1,primaquine,Primaquine diphosphate,,MODERATE,LOW,2.76,-3.67,1
4153.0,COC1C(=O)C2(C)C(OC)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C,,CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C,cabazitaxel,Cabazitaxel,NCGC00346704-07,LOW,INACTIVE,3.69,-5.31,0
1422.0,CC#CCC(C)C(O)C=CC1C(O)CC2CC(=CCCCC(=O)O)CC21,,CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,iloprost,Iloprost,,LOW,INACTIVE,4.22,-4.61,0
647.0,CC(NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,,C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,cinacalcet,Cinacalcet hydrochloride,NCGC00181002-10,HIGH,HIGH,5.49,-6.8,1
2245.0,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,prednisolone,Prednisolone,NCGC00179649-13,LOW,INACTIVE,1.64,-3.18,0
2105.0,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,pergolide,Pergolide methanesulfonate,,HIGH,LOW,4.17,-5.73,1
,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)C=CC=CC(O)(CC)CC)CC(O)CC1O,,C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/C=C/C(O)(CC)CC)C[C@@H](O)C[C@@H]1O,,Seocalcitol,,LOW,INACTIVE,6.58,-5.11,0
4942.0,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,lenvatinib,Lenvatinib,NCGC00263198-07,MODERATE,LOW,3.03,-4.84,1
,Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1,,Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1,,RG2833,,HIGH,LOW,2.61,-5.05,1
679.0,CCCCCCCCCCCCCCCC(=O)OC1C(SC)OC(C(NC(=O)C2CC(CCC)CN2C)C(C)Cl)C(O)C1O,,CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC,clindamycin palmitate,Clindamycin palmitate HCl,NCGC00185773-02,LOW,INACTIVE,7.02,-5.94,0
2056.0,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,papaverine,Papaverine hydrochloride,NCGC00015810-26,MODERATE,INACTIVE,4.19,-4.42,1
511.0,CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O,,CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O,carmofur,Carmofur,NCGC00095165-08,HIGH,LOW,2.57,-3.72,1
3098.0,CCOC(=O)COc1ccc2c(C)c(CCN(CC)CC)c(=O)oc2c1,,CCOC(=O)COc1ccc2c(C)c(CCN(CC)CC)c(=O)oc2c1,carbocromen,Chromonar hydrochloride,,HIGH,HIGH,3.55,-3.91,1
191.0,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,amoxapine,Amoxapine,,LOW,INACTIVE,2.8,-3.26,0
798.0,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1,,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1,delapril,Delapril hydrochloride,,LOW,INACTIVE,1.65,-4.93,0
1976.0,CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1,,CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1,buphenine,Nylidrin,,HIGH,LOW,3.07,-4.17,1
,NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCN4)cc3F)nc12,,NC(=O)c1cccc2[nH]c(-c3ccc([C@@H]4CCCN4)cc3F)nc12,,A-966492,NCGC00345451-04,MODERATE,HIGH,2.34,-4.19,1
,O=c1c(-c2ccccc2)c1-c1ccccc1,,O=c1c(-c2ccccc2)c1-c1ccccc1,,Diphenylcyclopropenone,,MODERATE,HIGH,3.72,-4.31,1
4145.0,CC(C=CC=C(C)C=CC1=C(C)CC(O)CC1(C)C)=CC=CC=C(C)C=CC=C(C)C=CC1C(C)=CC(O)CC1(C)C,,CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,lutein,Xanthophyll,,LOW,INACTIVE,8.28,-5.9,0
1904.0,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,nevirapine,Nevirapine,,LOW,INACTIVE,1.74,-3.4,0
,Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOCC3c3ccccc3)c2c1,,Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOC[C@@H]3c3ccccc3)c2c1,,,NCGC00483210-07,MODERATE,LOW,4.8,-3.84,1
2446.0,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,sirolimus,Sirolimus,NCGC00021305-08,MODERATE,LOW,4.82,-5.74,1
4569.0,CCCC(=O)OC1(C(=O)COC(=O)CC)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,,CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,hydrocortisone probutate,Hydrocortisone buteprate,,LOW,INACTIVE,3.83,-5.23,0
2207.0,CC1CCCC(C)N1CCCC(O)(c1ccccc1)c1ccccn1,,C[C@H]1CCC[C@@H](C)N1CCCC(O)(c1ccccc1)c1ccccn1,pirmenol,Pirmenol,,LOW,INACTIVE,4.27,-3.9,0
681.0,Oc1c(I)cc(Cl)c2cccnc12,,Oc1c(I)cc(Cl)c2cccnc12,clioquinol,Clioquinol,,HIGH,HIGH,3.67,-3.06,1
2277.0,Nc1ccc2cc3ccc(N)cc3nc2c1,,Nc1ccc2cc3ccc(N)cc3nc2c1,proflavine,Proflavin hemisulfate,,HIGH,LOW,2.1,-3.3,1
,Cc1nc(NS(=O)(=O)c2ccc(N)cc2)nc(C)c1Br,,Cc1nc(NS(=O)(=O)c2ccc(N)cc2)nc(C)c1Br,,Sulfabromomethazine,,LOW,INACTIVE,1.71,-3.53,0
,NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O,,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O,,MLN-4924,,MODERATE,LOW,2.18,-3.51,1
3194.0,CCOc1ccc2nc3cc(N)ccc3c(N)c2c1,,CCOc1ccc2nc3cc(N)ccc3c(N)c2c1,ethacridine,Ethacridine lactate hydrate,,MODERATE,LOW,2.49,-3.58,1
4190.0,N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,ruxolitinib,Ruxolitinib|INCB018424,NCGC00244253-18,HIGH,HIGH,2.94,-3.42,1
,Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1,,Cc1cccc(/C=N/Nc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1,,Apilimod mesylate,NCGC00263093-04,LOW,INACTIVE,3.91,-4.18,0
928.0,CCN(CC)C(=S)SSC(=S)N(CC)CC,,CCN(CC)C(=S)SSC(=S)N(CC)CC,disulfiram,Disulfiram,NCGC00016000-21,LOW,INACTIVE,3.88,-4.37,0
2269.0,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,probucol,Probucol,,MODERATE,LOW,8.92,-7.09,1
2749.0,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,alimemazine,Trimeprazine tartrate,,LOW,INACTIVE,4.98,-4.55,0
4292.0,Cc1ccc(C=C2C(=O)C3(C)CCC2C3(C)C)cc1,,Cc1ccc(/C=C2/C(=O)C3(C)CCC2C3(C)C)cc1,enzacamene,ENZACAMENE,,LOW,INACTIVE,5.09,-4.7,0
,CCCC(NC(=O)C(C#N)=Cc1cccc(Br)n1)c1ccccc1,,CCC[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1,,Degrasyn,,LOW,INACTIVE,4.31,-5.05,0
,Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1,,Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1,,LMK235,,LOW,INACTIVE,1.5,-3.28,0
,CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1,,CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1,,Givinostat hydrochloride,,LOW,INACTIVE,4.18,-4.91,0
,CCC(=O)Oc1ccc2c(c1)CCC1C2CCC2(C)C1CC(OC(=O)CC)C2OC(=O)CC,,CCC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1C[C@@H](OC(=O)CC)[C@@H]2OC(=O)CC,,Estriol tripropionate,,LOW,INACTIVE,5.52,-6.02,0
729.0,C=CC1(C)CC(=O)C2(O)C(C)(O1)C(OC(C)=O)C(OC(=O)CCN(C)C)C1C(C)(C)CCC(O)C12C,,C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](OC(=O)CCN(C)C)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,colforsin daropate,NKH477,,LOW,INACTIVE,1.95,-3.34,0
2181.0,NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,,NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,pipamperone,Pipamperone dihydrochloride,,LOW,INACTIVE,2.32,-3.31,0
707.0,Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1,,Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1,cloperastine,Cloperastine hydrochloride,,LOW,INACTIVE,5.08,-5.64,0
115.0,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,alfuzosin,Alfuzosin hydrochloride,,HIGH,HIGH,1.52,-3.14,1
,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,,Saracatinib,,MODERATE,INACTIVE,3.56,-3.76,1
1500.0,CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C,,CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C,isopropamide,Isopropamide,,LOW,INACTIVE,2.28,-6.96,0
,CCC1CN2CCc3cc(OC)c(OC)cc3C2CC1CC1NCCc2cc(O)c(OC)cc21,,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(O)c(OC)cc21,,Cephaeline,,LOW,INACTIVE,4.1,-4.84,0
,CC(C)C(C(=O)Nc1ccc(C(=O)NO)cc1)c1ccccc1,,CC(C)[C@H](C(=O)Nc1ccc(C(=O)NO)cc1)c1ccccc1,,AR-42(HDAC-42),NCGC00263153-07,MODERATE,INACTIVE,2.48,-4.5,1
,COc1ccc2sc(NC(c3ccc(OC(F)F)cc3)c3ccc4cccnc4c3O)nc2c1,,COc1ccc2sc(NC(c3ccc(OC(F)F)cc3)c3ccc4cccnc4c3O)nc2c1,,KIN1408,,HIGH,HIGH,5.64,-5.7,1
5241.0,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,betrixaban,Betrixaban,,HIGH,HIGH,2.86,-4.44,1
5202.0,CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,,CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,baricitinib,Baricitinib,,HIGH,LOW,1.04,-3.02,1
1045.0,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,erlotinib,Erlotinib,NCGC00164574-14,MODERATE,LOW,3.12,-4.64,1
,C=CCNc1c(O)cc2c(O)c1CC(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)C=CC=C(C)C(=O)N2,,C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)N2,,Retaspimycin (Hydrochloride),NCGC00346438-02,MODERATE,LOW,3.96,-4.53,1
2737.0,CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1,,CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1,tridihexethyl,Tridihexethyl chloride,,LOW,INACTIVE,2.31,-7.32,0
4758.0,Cc1ccc(C2OC(CO)C(O)C(O)C2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,,Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,canagliflozin,Canagliflozin,NCGC00346691-07,LOW,INACTIVE,3.14,-4.99,0
,O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12,,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,H-89,,LOW,MODERATE,2.68,-5.58,0
,CC1=C(O)C(=O)C=C2C1=CC=C1C2(C)CCC2(C)C3CC(C)(C(=O)O)CCC3(C)CCC12C,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]3(C)CC[C@@]4(C)CC[C@@](C)(C(=O)O)C[C@H]4[C@]3(C)CC[C@@]21C,,Celastrol,NCGC00178913-11,HIGH,HIGH,6.1,-5.3,1
894.0,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,,C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1,dilevalol,Labetalol HCl,,MODERATE,LOW,1.73,-4.75,1
3959.0,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,,CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,hydrocortisone butyrate,Hydrocortisone 17-butyrate,,LOW,INACTIVE,3.21,-4.5,0
361.0,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,bexarotene,Bexarotene,NCGC00181016-19,LOW,INACTIVE,6.87,-6.37,0
,COC(=O)C1(c2ccc(C)cc2)CC1CN1CCC(O)(c2ccccc2)CC1,,COC(=O)[C@@]1(c2ccc(C)cc2)C[C@H]1CN1CCC(O)(c2ccccc2)CC1,,(Â±)-PPCC oxalate,,LOW,INACTIVE,3.82,-4.39,0
611.0,Oc1c(Cl)cc(Cl)c2cccnc12,,Oc1c(Cl)cc(Cl)c2cccnc12,chloroxine,Chloroxine,,HIGH,HIGH,3.44,-3.19,1
2571.0,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,tazarotene,Tazarotene,NCGC00167525-11,HIGH,HIGH,5.15,-5.67,1
2757.0,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,trimetrexate,Trimetrexate,NCGC00161419-06,MODERATE,LOW,2.36,-4.08,1
321.0,CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1,,CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1,benziodarone,Benziodarone,,MODERATE,LOW,5.79,-4.57,1
3689.0,Nc1nc(-c2ccccc2)c(Br)c(=O)[nH]1,,Nc1nc(-c2ccccc2)c(Br)c(=O)[nH]1,bropirimine,Bropirimine,,LOW,INACTIVE,1.43,-3.12,0
128.0,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,almotriptan,Almotriptan,NCGC00095135-12,LOW,INACTIVE,2.0,-3.44,0
179.0,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,amisulpride,Amisulpride,NCGC00092310-14,LOW,INACTIVE,1.5,-3.1,0
3514.0,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,quercetin,Quercetin,NCGC00015870-26,MODERATE,INACTIVE,1.81,-3.06,1
4889.0,C=CC1CC1(NC(=O)C1CC(Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,asunaprevir,Asunaprevir (BMS-650032),,LOW,INACTIVE,3.26,-5.4,0
4318.0,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC1CCOC1,,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,afatinib,Afatinib (BIBW2992),NCGC00185000-18,MODERATE,LOW,3.79,-4.58,1
4892.0,CCc1ccc(Cc2ccc3c(c2)C2(OC3)OC(CO)C(O)C(O)C2O)cc1,,CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,tofogliflozin,Tofogliflozin (hydrate),,LOW,INACTIVE,1.5,-3.07,0
761.0,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,cyclothiazide,Cyclothiazide,,LOW,INACTIVE,1.32,-3.15,0
,O=C(O)c1ccccc1C(c1ccc(O)cc1)c1ccc(O)cc1,,O=C(O)c1ccccc1C(c1ccc(O)cc1)c1ccc(O)cc1,,Phenolphthalin,,LOW,INACTIVE,4.29,-4.14,0
1605.0,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,loratadine,Loratadine,,MODERATE,INACTIVE,4.82,-4.46,1
,CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(S(C)(=O)=O)cc1,,CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(S(C)(=O)=O)cc1,,FIROCOXIB,,LOW,INACTIVE,2.98,-4.51,0
,COc1ccc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2OC)cc1O,,COc1ccc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2OC)cc1O,,Casticin,,LOW,INACTIVE,2.71,-3.9,0
,COc1c2c(cc3c1-c1c(cc4c(c1OC)OCO4)CC(C)C(C)C3)OCO2,,COc1c2c(cc3c1-c1c(cc4c(c1OC)OCO4)C[C@@H](C)[C@@H](C)C3)OCO2,,Schisandrin C,,LOW,INACTIVE,4.01,-4.37,0
,O=C1OC2(c3ccccc31)c1cc(I)c(O)c(I)c1Oc1c2cc(I)c(O)c1I,,O=C1OC2(c3ccccc31)c1cc(I)c(O)c(I)c1Oc1c2cc(I)c(O)c1I,,Erythrosin B,,MODERATE,LOW,4.87,-5.39,1
1154.0,CC(C(=O)O)c1cccc(Oc2ccccc2)c1,,CC(C(=O)O)c1cccc(Oc2ccccc2)c1,fenoprofen,Fenoprofen calcium salt dihydrate,,LOW,INACTIVE,3.87,-3.48,0
,CCCCCCCCCC(=O)OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,CCCCCCCCCC(=O)OCCN1CCN(CC/C=C2\c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,FLUPENTIXOL DECANOATE,,LOW,INACTIVE,7.2,-6.74,0
,COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2,,COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2,,Elacridar,,HIGH,MODERATE,5.46,-5.3,1
,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,PJ34 Hydrochloride,,MODERATE,MODERATE,1.86,-3.55,1
,CC(CN1CCCC1)C(=O)c1ccc(C(F)(F)F)cc1,,C[C@H](CN1CCCC1)C(=O)c1ccc(C(F)(F)F)cc1,,Lanperisone hydrochloride,,LOW,INACTIVE,3.39,-3.92,0
1077.0,CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC,,CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC,ethaverine,Ethaverine hydrochloride,,HIGH,LOW,5.76,-5.65,1
1675.0,CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21,,CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21,melitracen,Melitracen hydrochloride,,LOW,INACTIVE,5.58,-4.96,0
5222.0,NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12,,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,niraparib,MK-4827|Niraparib,,HIGH,LOW,2.45,-4.33,1
